Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28651306 | 0.92 | KMT2A (0.35) | KMT2APKMHSD17B10LMNAHTT | |
| SCHEMBL6896590 | 0.86 | KMT2A (0.41) | KMT2ALMNAALDH1A1GAA | |
| SCHEMBL31213825 | 0.82 | KMT2A (0.39) | KMT2ALMNAALDH1A1GAA | |
| Chloroform SCHEMBL28983248 | 0.79 | KMT2A (0.37) | KMT2AALDH1A1GAA | |
| SCHEMBL113935 | 0.78 | LMNA (0.39) | LMNA | |
| SCHEMBL17225884 | 0.77 | LMNA (0.48) | KMT2APKMHSD17B10LMNAHTT | |
| SCHEMBL28992753 | 0.77 | LMNA (0.32) | LMNA | |
| SCHEMBL28514761 | 0.75 | CA12 (0.38) | KMT2APKMHSD17B10LMNARECQL | |
| SCHEMBL15746700 | 0.74 | PKM (0.33) | PKMHSD17B10 | |
| SCHEMBL15746699 | 0.74 | PKM (0.33) | PKMHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12168217-B2 | Polyorganic functional groups modified silica, processes to make and use thereof | SI-NOVATION LTD (CN) | 2024-12-17 | — | — | US | disclosed |
| CN-117380223-A | Rhodium-based catalyst, preparation method and application thereof | 北京高新利华科技股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-117380284-A | Rhodium-based catalyst and preparation method and application thereof | 北京高新利华科技股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20190176124-A1 | POLYORGANIC FUNCTIONAL GROUPS MODIFIED SILICA, PROCESSES TO MAKE AND USE THEREOF | SI-NOVATION LTD (CN) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190176124-A1 | POLYORGANIC FUNCTIONAL GROUPS MODIFIED SILICA, PROCESSES TO MAKE AND USE THEREOF | STAMBP, TST, AS3MT | KMT2A 2551/4885PKM 1361/4885HSD17B10 4754/4885 |
| US-12168217-B2 | Polyorganic functional groups modified silica, processes to make and use thereof | STAMBP, TST, AS3MT | KMT2A 2551/4885PKM 1361/4885HSD17B10 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.